Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study
- PMID: 29315341
- PMCID: PMC5760031
- DOI: 10.1371/journal.pone.0190249
Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study
Abstract
Object: Despite many efforts at reduction, cerebrospinal fluid (CSF) shunt infections are a major cause of morbidity in shunt surgery, occurring in 5-15% of cases. To attempt to reduce the shunt infection rate at our institution, we added topical vancomycin (intrashunt and perishunt) to our existing shunt infection prevention protocol in 2012.
Methods: We performed a retrospective cohort study comparing all shunted patients in January 2010 to December 2011 without vancomycin (control group, 263 procedures) to all patients who underwent shunt surgery between April 2012 and December 2015 with vancomycin (intervention group, 499 procedures).
Results: The overall shunt infection rate significantly decreased from 6.8% (control group) to 3.0% (intervention group) (p = 0.023, absolute risk reduction 3.8%, relative risk reduction 56%). Multivariate logistic regression analysis confirmed that the addition of topical vancomycin showed that cases treated under a protocol of topical vancomycin were associated with a decreased shunt infection rate (odds ratio [OR] 0.49 95% CI 0.25-0.998; p = 0.049). Age < 1 year was associated with an increased risk of infection (OR) 4.41, 95% CI 2,10-9,26; p = 0.001). Time from surgery to infection was significantly prolonged in the intervention group (p = 0.001).
Conclusion: Adding intraoperative vancomycin to a shunt infection prevention protocol significantly reduces CSF shunt infection rate.
Conflict of interest statement
References
-
- Borgbjerg BM, Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien). 1995;136(1–2):1–7. . - PubMed
-
- Cochrane DD, Kestle JR. The influence of surgical operative experience on the duration of first ventriculoperitoneal shunt function and infection. Pediatr Neurosurg. 2003;38(6):295–301. doi: 70413. doi: 10.1159/000070413 . - DOI - PubMed
-
- James G, Hartley JC, Morgan RD, Ternier J. Effect of introduction of antibiotic-impregnated shunt catheters on cerebrospinal fluid shunt infection in children: a large single-center retrospective study. J Neurosurg Pediatr. 2014;13(1):101–6. doi: 10.3171/2013.10.PEDS13189 . - DOI - PubMed
-
- Kestle JR, Holubkov R, Douglas Cochrane D, Kulkarni AV, Limbrick DD Jr., Luerssen TG, et al. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection. J Neurosurg Pediatr. 2016;17(4):391–6. doi: 10.3171/2015.8.PEDS15253 . - DOI - PubMed
-
- Kestle JR, Riva-Cambrin J, Wellons JC 3rd, Kulkarni AV, Whitehead WE, Walker ML, et al. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr. 2011;8(1):22–9. doi: 10.3171/2011.4.PEDS10551 ; PubMed Central PMCID: PMCPMC3153415. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
